Position in OMER
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$407,975
-$213,941 QoQ
Shares Held
38,634
+6.7% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in OMER Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $374,315,342 across 207 Biotechnology names. OMER ranks #110 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
70,804 | $31,616,818 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
80,930 | $26,074,836 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
152,645 | $25,800,057 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
374,931 | $24,231,790 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
23,567 | $18,208,806 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
1,805,184 | $17,004,833 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
1,738,062 | $15,659,938 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.\DE
|
708,527 | $13,858,788 |
All Filings in OMER
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $407,975 | 38,634 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $621,916 | 36,200 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $84,066 | 20,504 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $101,961 | 33,987 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $279,373 | 33,987 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $343,092 | 34,726 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $137,862 | 34,726 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $140,987 | 34,726 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $72,850 | 21,116 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $105,509 | 32,266 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $94,216 | 32,266 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $175,527 | 32,266 | Shares | Defined | 2023-08-10 | |
| 2022-03-31 | $174,091 | 28,967 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $77,835 | 12,105 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $319,362 | 23,159 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $343,679 | 23,159 | Shares | Defined | 2023-03-23 | |
| 2021-03-31 | $412,230 | 23,159 | Shares | Defined | 2023-03-23 | |
| 2020-12-31 | $385,601 | 26,984 | Shares | Defined | 2023-03-23 | |
| 2020-09-30 | $272,808 | 26,984 | Shares | Defined | 2023-03-23 | |
| 2020-06-30 | $397,204 | 26,984 | Shares | Defined | 2023-03-23 | |
| 2020-03-31 | $286,920 | 21,460 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||